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Abstract
Background
The effects of surgical procedures and the need for life-long nutrient
supplementation may impact on medication regimes, requiring changes to
dosage and formulation of medicines, which can be difficult for patients
following surgery. Our pre-surgical assessment pathway involves a pharmacist
with specialist knowledge of bariatric surgery, to help prepare patients for
these changes.
Objective














National Health Service Hospital, United Kingdom.
Methods
A two phased, retrospective study design using participants recruited from
pre-surgical clinic lists. The first phase consisted of confidential, face to face
semi-structured interviews. A constant comparative analytic framework
informed the construction of the second phase, which consisted of a
confidential survey to test the generalizability of the findings with a larger
cohort of patients.
Results
A total of 40 participants (12 interviews, 28 surveys) were recruited to the
study. The majority of participants were female (n = 33), mean age 50 years,
mean pre-surgical weight 124 kg (n = 38). The most common comorbidity was
type 2 diabetes. Participants on medication had at least one comorbidity, with
the majority of conditions improved or eliminated after surgery.
Conclusions
The pre-surgical consultation with the pharmacist was highly valued by the
participants, providing information and support which helped prepare for
medication changes after bariatric surgery. Many felt that a post-surgical
appointment with the pharmacist would provide support and improve
compliance with vitamins and medications. Future research into the role of













Many people with obesity who seek bariatric surgery have related comorbidities,
necessitating polypharmacy. In the UK, 64% of patients undergoing bariatric
procedures have three or more obesity-related health conditions [1]. The
malabsorptive and restrictive effects of bariatric surgical procedures and
resultant rapid weight loss necessitate life-long vitamin and mineral
supplementation surgery [2]. This often means altered pharmacokinetics of
medications, e.g. dose, formulation and timing [3, 4] which vary according to the
individual health status of patients. Additionally, there is a need for lifelong
follow-up and nutritional supplementation. Bariatric surgery is time of immense
physical, social and personal change [5, 6] which requires a period of adjustment
for patients.
To prepare for surgery, UK patients attend appointments with members of the
bariatric multi-disciplinary team (MDT) to ensure that they meet individualised
targets, e.g. weight loss or changes to health behaviours, demonstrating their
ability to adapt to post-surgical lifestyle changes [7]. Once a patient is cleared
for surgery, they attend our pre-surgical assessment clinic which has an
embedded pharmacist as part of our MDT. During pre-surgical assessment, all
patients have an appointment with the pharmacist, who carries out a medication
review, integrating changes to current medication post-surgery, discusses
compliance with nutritional supplementation after surgery, highlighting issues
regarding the timing, duration and interaction with specific medication and
vitamins. The pharmacist actively encourages patients to ask questions and
discuss their concerns. At the end of the appointment, a written summary is
given to the patient, with copies sent to their General Practitioner and
incorporated into their hospital records to ensure that information is available to
all parties involved in the patients’ care.
There is an increasing drive to involve patients in clinical research to ensure that
studies are carried out which are relevant to patients and provide opportunities
for patients to be included in decisions about research from design to
dissemination [8]. In the UK, as part of ethical approval process for research
carried out in National Health Services (NHS) settings, applications must
demonstrate patient involvement in the research as part of the approval process
[9].
Our unit actively carries out patient-focused research, with and for patients. The
idea for this study was based on findings from a previous study which explored
how patients adjust to life after bariatric surgery [5]. Findings showed that
patients reported issues around medication and supplementation compliance
which warranted further investigation. Many participants discussed the
importance of pre-surgical contact with the bariatric MDT in preparing for and
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adjusting to life after surgery which we decided to explore further with this
study.
The inclusion of a pharmacist in pre-surgical pre-assessment is unique to our
service and is not standard practice within UK bariatric surgical units. In order to
further engage with patients to co-create research studies which incorporate the
views and needs of our patients, the aim of this study was to explore the patient-
reported impact of the pharmacist in pre-bariatric surgical assessment.
Methods
A retrospective, two phased, study design with participants randomly recruited
from pre-surgical assessment clinic lists by an independent researcher in a large
National Health Service (NHS) hospital in the UK. As all patients in our service
attend pre-surgical assessment, all patients on the pre-surgical clinic lists were
eligible to participate. The first phase involved individual, face to face semi-
structured interviews, assisted by a topic guide, which were audio-recorded and
transcribed verbatim. Participants were asked to voluntarily take part by
discussing their experiences of seeing the pharmacist during pre-surgical
assessment. Each interview was carried out by the same independent researcher
and took between 30 and 45 min. A constant comparative approach was used,
which means that data collection and analysis were undertaken concurrently,
with analysis guiding further sampling [10]. This approach allowed researchers
to discover areas of interest and to identify concepts of importance to
participants and explore these further. Data collection and analysis continued
until no new concepts were identified, meaning data was saturated and
recruitment to phase 1 ceased. The findings informed the construction of the
second phase, which consisted of a confidential survey to test the
generalizability of the findings with a larger cohort of patients. During the
interviews and data analysis for phase 1, it was noted that participants preferred
to discuss the impact of the pharmacist appointment in terms of preparation for
surgery, dealing with changes to health status and medication after surgery.
Participants did not routinely discuss amount of weight loss, despite collecting
data on this as part of the participant demographics. In order to focus on the aim
of the study and to reduce the number of questions to encourage responses,
questions around weight loss were not included in the survey. Prior to
distributing study information, the survey was pilot tested with a representative
group of patients, who confirmed that the emphasis should be on patient
experiences and not on clinical outcomes.
For phase 2, participants were also identified from clinic lists, with an
information pack containing the study information and a link to an on-line
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survey using Survey Monkey®, with the option of requesting a printed copy, by
post. To protect confidentiality, no reminders were sent. Ethical approvals were
granted by the National Health Service, Hospital and University research ethics
committees. Data were collected between April 2017 and January 2018.
Results
A total of 40 participants (33 female, 7 male) took part in the study, with 12
being interviewed (phase 1) and 28 filling in on-line and printed surveys (phase
2). Owing to a continuous and varied flow of patients progressing to surgery
through the pre-surgical assessment pathway as data was collected, an accurate
response rate could not be determined. The nature of qualitative research means
that sample sizes are smaller than quantitative studies [11] as the aim of
qualitative research is to observe, understand, and explore a phenomena
inductively, paying attention to the meaning and actions of participants, as
opposed to entering a study with a pre-determined hypothesis and generating
large quantities of numerical data [12]. A qualitative approach is therefore
helpful in illuminating and understanding individual and collective patient
experiences, which can assist in further developing support for individuals who
undergo bariatric surgery.
First Phase—Interviews
Twelve participants (11 female, 1 male) consented to be interviewed (see Table
1). All participants had undergone bypass operations, with Roux-n-Y procedures
(n = 7), one anastomosis gastric bypass (n = 4, and a revisional sleeve
gastrectomy to Roux-en-gastric bypass). Participants’ ages ranged from 45 to
63 years (mean age 56 years) and the time since surgery ranged from 6 to
24 months (mean time 13 months) at time of interview. The pre-operative weight
of participants ranged from 102 to 154 kg (mean pre-operative weight 124 kg)
with weight loss since surgery ranging from 12 to 70 kg (mean weight loss
42 kg).
Table 1































































































































The interviews took place in a location of participants’ choice, including place
of work, hospital, and their homes. Each participant gave written consent; the
interview was audio-recorded and transcribed verbatim. The researcher also took
written notes during the interview, to note areas of interest to be explored
further, and to clarify any ambiguity to ensure that interpretation of data was
veracious to the participants’ experience and to minimise researcher bias.
Transcripts were compared with earlier transcripts in a process known as
constant comparative analysis, allowing researchers to identify concepts of
interest. The concepts were discussed with the research team and a core set of
emergent themes was identified and agreed (see Table 2) which informed the
construction of the general survey questions, for phase 2.
Table 2
Themes constructed from interviews
Theme In vivo quotes
Taking pills
signifies illness
My Dad died from kidney and liver failure and some of this was
down to the medication he was on. Because of this, I did not want
to take tablets the rest of my life, and I had side effects from my
blood pressure tablets. I have lost weight and I do not have
symptoms anymore and I want to come off the pills, I do not want
any side-effects long or short term. With the vitamins I am on
seven tablets a day and I do not want to take so many (Participant
L)
I understand that I am taking vitamins for my health and to
protect myself in the future. I see it as a priority but it is still




I wasn’t as scared as I thought I would be because she
[Pharmacist] talked us [self and partner]through what would
happen around the medications after surgery and I think she made
me feel more confident in myself (Participant A)
The pharmacist told me that I would have to crush to tablets and
it might taste bitter, and to have a drink afterwards to take the
taste away. When I was on the ward, I got my tablet from the
staff, and they just handed it to me whole. I felt good about
telling them that the pharmacist told me the tablet needed to be






I had not thought through as to what medication was going to be
needed afterwards, so it was good to have the update. If I had not
had the appointment, then just been presented with tablets when I








With my husband with me at the appointment, he heard
everything the pharmacist said and why I needed to take these
tablets. So now, he will tell me to make sure I take my tablets on
a morning, and reminding me again at night, because I used to be
terrible about forgetting to take my pills (Participant A)
I had an appointment with my GP and I explained I had met with
the pharmacist and I actually took the sheet of paper with me for
the GP to have a look at and I went through with her what had
been explained to me and the GP asked how I felt about things. I
said that I felt a lot better and the information helped my GP to
understand what I needed (Participant B)
The GP gave me the tablets to stop the gallstones, but he did not
give me enough, or the right dosage. I had to go back and back,
so when the letter came I went back with it and said to the GP





If I had not seen the pharmacist, I would have probably been
more scared waking up the next day after the operation and
someone coming up and saying I had to take these tablets. I
thought it was quite interesting to speak with the pharmacist
about this well before the operation (Participant A)
Nobody, except the pharmacist, told me about not being able to
take certain medications anymore. She explained why I could not
take co-codamol after surgery. She said if I had a migraine, I
would need to take paracetamol and that I had to cut codeine out
completely. I was worried as I was reliant on it at the time, but I
appreciated the time she took to explain everything to me
(Participant K)
My pharmacist appointment was critical. You need to understand
what you are taking and why you are taking it, but also having the
structure. It was really clear when I came out of the appointment
what I needed to do and when. I think if I had not met with her, I
probably would not be as informed as I am (Participant L)
Wanting to help
others
When I was in hospital having the operation, I met a man in the
next bed who showed me an app for my phone, where I entered
all my medication, the time, the quantity etc. and it tells me when
to take it and everything else. It’s called Medisafe, and it has been
so helpful. I’d recommend it to others, as it even tells you when
you are running low, so you can order a new prescription
(Participant E)
After the pharmacist appointment, I bought a pill box, and it
helped me to organise myself and my tablets. I would tell
everyone to do this, as there is so much to think about after
surgery and you need to be prepared (Participant H)
Second Phase
A total of 28 (22 females, 6 males) completed the survey (on-line or print) (see
Table 3). The types of procedures performed were Roux-n-Y Gastric bypass 64%
(n = 18), mean pre-surgical weight was 128 kg. The most commonly reported
health conditions were type 2 diabetes (n = 8), pain (n = 6), and hypertension (n 
= 6). Improvements to health conditions were reported by 71% (n = 20) of
participants, with 7% (n = 2) reporting it was too early to notice a change, 3% (n 
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= 1) had a chronic disease flare-up post-surgery and 18% (n = 5) did not respond
(see Table 3).
Table 3
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14 F 51 2 SleeveGastrectomy 91
T2D, high
blood pressure












































































































25 F 27 6 SleeveGastrectomy 144 None reported












Most participants were aware they were going to see a pharmacist as part of pre-
surgical assessment. Patients attended the appointment alone or with someone
else and spent between 10 and 30 min with the pharmacist. The participant-
































































1 Cannotremember 15 Alone
What medications I









2 Yes 15 Withpartner
What I should be eating







stop or start and why.
Also gave me
information on two
types of procedures and
the effects of these on
medications, as I was
not sure which operation










5 Yes 10 Alone hHelp with weight lossafter surgery Yes
6 Yes 30 Withpartner
Awareness of what









7 CannotRemember 10 Alone No response Yes





9 Yes 10 Alone Everything Yes





11 Yes 15 Alone
To stop taking Naproxen
or use Ibuprofen gel so
as to not aggravate my
stomach. Finding out
what other medications I
would need.
Yes







14 No 20 Withpartner
Explanation of what the
new medicines I had to
take were for
Yes







That I have to take
certain medications for









17 Yes 15 Alone
Need for vitamins the
lady also had a bottle
with salt in and
explained how much
salt was in soluble pain
killers also told me not
take certain pills at
same time, i.e. calcium
and iron
Yes
18 Yes 20 Withpartner
I was given a list of
what I would be taken
and for how long all my
questions were
answered and she noted
all information so I left
feeling confident
Yes
19 Yes 30 Alone How important medsand aftercare are Yes
20 Yes 20–30 Alone
the reasons why some
medications cannot be
taken and why it was








21 Yes 30 Withpartner
Some medication would
change from tablets to
liquid form
Yes
22 Yes 30 Withpartner  Yes
23 Yes 30 Alone
The pharmacist gave me
the important
information I needed to
know about post-surgery
so I was aware of what
to expect and how
important it was to
maintain the regime.
She was also kind
enough to answer the






24 Yes 10–15 Alone importance of notmissing medication Yes
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The pre- and post-surgical changes to medications are outlined in Table 5, with
the majority showing a reduction in medications. Although phase 1 identified a
dichotomy between prescription medications and nutrient supplementation in the
context of taking pills daily, the majority of respondents in phase 2 did not
perceive vitamins and minerals as ‘medication’.
25 No 10 Alone None it was very un-informative No








for 6 months which was
a relief to hear, and that
the only medication I
would take for life
would be a multivitamin
and mineral supplement.
Yes
27 Yes 20 Withpartner
Helped me understand
what I needed to take







How I was going to take
medication, i.e. soluble





























































































































































































































































































































































































The final phase of the survey asked participants to reflect on the role of the
pharmacist (see Table 6). Over three quarters felt that the pharmacist input was
valuable or extremely valuable, with high levels of confidence in taking
medication post-surgically. Over half (n = 16) stated the service could be
improved with additional appointments with the pharmacist after surgery.
Table 6
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Participants were asked how the pharmacist service could be developed further
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‘I recommend that all patients are told to buy a pill organiser
before surgery’
‘Having a pharmacist available for patients who are discharged
on a weekend’
‘A more detailed leaflet which describes all the vitamins and
what to take and when’
‘It was all explained very well to me, but listening to the other
patients on the ward after surgery I feel that some people just
don’t listen carefully to the pharmacist, who explained everything
to me without being patronising’
‘It would be great to have an on-line Question and Answer
session so that if your General Practitioner leaves you hanging, as
mine did, you can get answers to your questions without needing
a hospital appointment’
‘More information on being aware of how hard it is to take
tablets after surgery’
‘I firmly believe that the pharmacists’ involvement in bariatric
surgery is crucial. Patients such as myself need a lot of support
pre- and post-operatively, and the information regarding
medication and how/when to take them and why they are being
taken is important to keeping us patients healthy and consistent in
our progress’
Discussion
Many participants felt they had become experts in their medicines management
and acted as an intermediary between the bariatric unit and the primary care
team responsible for their long-term care and follow-up, reporting that general
practitioners were often not aware of the need to both alter medication regimes,
or the necessity of lifelong vitamin supplementation.
The act of taking pills was important for participants. For those on multiple
medications for comorbidities, a reduction in the number of pills taken each day
signified a positive improvement in their post-surgical lives. However, the need
for additional pills in the form of vitamins and temporary (6 month) medications
added a layer of complexity to the adjustment after surgery in terms of
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expectations. Participants felt that although medications were ‘bad’ and vitamins
were ‘good’ in terms of complying with post-surgical advice and being healthy,
the act of taking pills itself was difficult. Additionally, there were reported side
effects of vitamins and supplements (e.g. constipation with ferrous fumarate),
and timing of vitamins to avoid interactions with medications was difficult to
deal with and affected compliance. For some participants, it was difficult to
separate pills in terms of medication and vitamins, for others, the dichotomy
between good (vitamins) and bad (medications), despite the number of tablets
taken increased after surgery, was not as much of an issue and was accepted as
part of the post-surgical lifestyle. It was noted in Table 5 that there were
inconsistencies in the patient-reported medicines after surgery, in that some
patients did not mention the post-operative medications, or did not mention
vitamins.
The discussion with the pharmacist was also thought to be an important step in
self-care and empowerment following surgery. Patients reported downloading
medication reminder apps on their mobile phones, carrying their medication list
with them, and having pills in certain locations (home, work, handbags) to be
accessible during the day and improve compliance.
Participants also reported using the information gained from the pharmacist to
initiate discussions with others involved in their care, notably their general
practitioners. Some participants reported using the information sheet supplied by
the pharmacist in pre-surgical assessment as a tool to initiate discussion with
their GPs around what was needed after surgery.
Conclusions
Overall, the pharmacist role in the pre-surgical assessment was largely perceived
by all participants as positive. The findings are limited to a small sample size of
patients in one bariatric surgical unit in the UK and may not be generalizable to
other bariatric surgical populations. Additionally, it is noted that it was more
difficult to recruit participants to take part in the surveys. It is accepted that there
is a high rate of patients who do not attend for follow-up appointments after
surgery, so they may also not wish to take part in research; therefore, it cannot
be excluded that the participants recruited for this study may not reflect the
opinions of the total patient population within our service. Owing to the
underpinning interpretivist framework which focuses on participants’
experiences using self-reported information, many participants were not able to
give specific information about the doses they were on and often expressed
changes colloquially, e.g. ‘two tablets instead of four’, making it difficult to
provide statistically valid information; however, the aim of the study was to
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understand the patient-reported impact of the role of the pharmacist and not
provide a quantitative measurement of compliance.
The themes of self-care and patient empowerment can be framed under an
overall concept of gaining control, which has been identified as important within
the bariatric surgical population. Pre-surgically, many people feel out of control,
and afterwards regain a sense of control over their lives [13, 14].
The pharmacist is a valued resource by patients as part of their pre-surgical
assessment, but consideration should be given to further appointments post-
surgically to address medication issues following weight loss and changes to
health status, to reinforce the importance of life-long vitamin supplementation
and management of potential side effects. Currently, the pharmacist role is
limited to pre-surgical assessment, but there is potential for pharmacists to
become more involved in the management of patients following surgery,
particularly in the management of long-term chronic diseases [15]. Further
research into the role of pharmacist as an integral part of the MDT in bariatric
patient care is recommended, along with ascertaining education and training for
this specialist role in practice.
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